Facebook
Twitter
LinkedIn
ForwardRecorded Presentations from the NCCN 11th Annual Congress: Hematologic Malignancies™
Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.
Target Audience
These educational programs are designed to meet the educational needs of oncologists, hematologists, nurses, pharmacists, and other healthcare professionals who manage patients with hematologic malignancies.
These activities are approved for AMA PRA Category 1 Credits™. Nursing and pharmacy (ACPE) credits may also be provided. Please refer to the complete accreditation information provided before the individual educational activity for more details.